Prestige Consumer Healthcare
PBH
#3920
Rank
HK$23.30 B
Marketcap
HK$484.59
Share price
-4.49%
Change (1 day)
-24.77%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): HK$31.63

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is HK$31.78. In 2024 the company made an earnings per share (EPS) of HK$33.66 an increase over its 2023 EPS that were of -HK$12.60.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$31.63-6.02%
2024HK$33.66-367.08%
2023-HK$12.60-138.33%
2022HK$32.8811.7%
2021HK$29.4413.6%
2020HK$25.91-651.67%
2019-HK$4.70-148.78%
2018HK$9.63-83.29%
2017HK$57.62437.23%
2016HK$10.73-34.13%
2015HK$16.2852.94%
2014HK$10.65-8.11%
2013HK$11.59
2011HK$6.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.19 174.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
HK$54.10 70.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.62 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.65-66.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$29.35-7.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
HK$48.15 51.48%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
HK$3.13-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.50-7.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
-HK$231.88-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
HK$9.55-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel